Log in

NASDAQ:WGBS - WaferGen Bio-systems Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume77,872 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
WaferGen Bio-systems, Inc (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company's ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:WGBS
CUSIPN/A
Phone+1-510-6514450

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive WGBS News and Ratings via Email

Sign-up to receive the latest news and ratings for WGBS and its competitors with MarketBeat's FREE daily newsletter.


WaferGen Bio-systems (NASDAQ:WGBS) Frequently Asked Questions

What is WaferGen Bio-systems' stock symbol?

WaferGen Bio-systems trades on the NASDAQ under the ticker symbol "WGBS."

Has WaferGen Bio-systems been receiving favorable news coverage?

News stories about WGBS stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. WaferGen Bio-systems earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave media headlines about the medical research company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future. View News Stories for WaferGen Bio-systems.

What other stocks do shareholders of WaferGen Bio-systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other WaferGen Bio-systems investors own include AEterna Zentaris (AEZS), BIOLINERX LTD/S (BLRX), DarioHealth (DRIO), Vascular Biogenics (VBLT), XOMA (XOMA), Conatus Pharmaceuticals (CNAT), NovaBay Pharmaceuticals (NBY), Anavex Life Sciences (AVXL), Chromadex (CDXC) and Corbus Pharmaceuticals (CRBP).

What is WaferGen Bio-systems' official website?

The official website for WaferGen Bio-systems is http://www.wafergen.com/.

How can I contact WaferGen Bio-systems?

WaferGen Bio-systems' mailing address is 34700 Campus Dr, FREMONT, CA 94555-3612, United States. The medical research company can be reached via phone at +1-510-6514450.


MarketBeat Community Rating for WaferGen Bio-systems (NASDAQ WGBS)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  139 (Thanks for Voting!)
Underperform Votes:  145 (Thanks for Voting!)
Total Votes:  284
MarketBeat's community ratings are surveys of what our community members think about WaferGen Bio-systems and other stocks. Vote "Outperform" if you believe WGBS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WGBS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel